Home FDA labels 1aba1ec4-489d-0e5d-e063-6394a90a6b99 FDA label 1aba1ec4-489d-0e5d-e063-6394a90a6b99 openFDA label record# This page contains supplementary openFDA label data. For the canonical label presentation, use the corresponding DailyMed Structured Product Label.
Verified complete openFDA source JSON (canonical bytes are SHA-256 checked before publication)
SPL set ID 80278ca9-ab01-e813-e053-2991aa0af461
SPL ID 1aba1ec4-489d-0e5d-e063-6394a90a6b99
Version 4
Effective date 2024-06-12
Source export date 2026-11-06
Source partition 1
Source file https://download.open.fda.gov/drug/label/drug-label-0001-of-0014.json.zip
Source object key raw/openfda/drug-label/2026-11-06/d46c999c1947092f6e18e5233482e6d1c02312c89d32ce906e3b19672a696546/drug-label-0001-of-0014.json.zip
Source manifest SHA-256 8dff71fbef1291eb7711013e9a3a06194930757924a8946ae3034107a98d9463
Import run 20261106T075659Z
Imported at 2026-11-06 08:07:20 Harmonized identifier links# Every typed identifier imported from the complete openFDA harmonization object is paginated here; values are not reduced to a first match.
Harmonized identifiers page 1 of 1 · 2 matching rows.
Adverse reactions cross-check# openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.
Adverse reactions sections page 1 of 1 · 2 matching rows.
adverse reactions ADVERSE REACTIONS The following local adverse reactions are reported infrequently with topical corticosteroids, but may occur more frequently with the use of occlusive dressings. These reactions are listed in an approximate decreasing order of occurrence: Burning Hypertrichosis Maceration of the skin Itching Acneiform eruptions Secondary infection Irritation Hypopigmentation Skin atrophy Dryness Perioral dermatitis Striae Folliculitis Allergic contact dermatitis Miliaria
adverse reactions table <table width="98%" ID="ID30"><colgroup><col width="33%"/><col width="27%"/></colgroup><tbody><tr><td align="left" styleCode="Toprule" valign="top">Burning</td><td align="left" styleCode="Toprule" valign="top">Hypertrichosis</td><td align="left" styleCode="Toprule" valign="top">Maceration of the skin</td><td align="left" valign="top">Itching</td><td align="left" valign="top">Acneiform eruptions</td><td align="left" valign="top">Secondary infection</td><td align="left" valign="top">Irritation</td><td align="left" valign="top">Hypopigmentation</td><td align="left" valign="top">Skin atrophy</td><td align="left" valign="top">Dryness</td><td align="left" valign="top">Perioral dermatitis</td><td align="left" valign="top">Striae</td><td align="left" valign="top">Folliculitis</td><td align="left" valign="top">Allergic contact dermatitis</td><td align="left" valign="top">Miliaria</td></tr></tbody></table>
Reported adverse events (FAERS/openFDA)# Adverse event summaries are temporarily unavailable. Other product information remains available.